Why Iradimed Stock Soared Today

The stock of advanced medical devices maker Iradimed (NASDAQ: IRMD) was the very picture of health on Tuesday. The company released its latest earnings report, which revealed that -- for the 18th quarter in a row -- it set a new all-time high revenue figure. Also, both the top and bottom lines rose at double-digit rates. Investors rewarded this by trading the stock up by nearly 10% that day. In its fourth quarter of 2025, Iradimed earned $22.7 million in revenue, a 17% improvement over the same period of 2024. Net income not in accordance with generally accepted accounting practices (GAAP) flew higher, rising 23% to just under $7 million ($0.54 per share). Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool